Revolution-Medicines

13
Apr

EverHint Stock Market News — April 13, 2026 — Breaking Developments (morning update, Pacific Time)

Iran ceasefire collapses as Trump orders Hormuz blockade—oil surges above $100. Goldman beats on earnings but trading miss weighs. Biotech explodes: Revolution Medicines +33%, Allogene +36%. $NVDA rumors lift $DELL +6%, HP +5%. Pershing Square launches $10B dual IPO. $LVMH luxury sales disappoint.
12 min read
09
Jan

EverHint Latest Market News — January 9, 2026 (last 24 hours) — Breaking Developments

S&P 500 hits record high on soft jobs data. Glencore-Rio mega-merger could form world's largest miner. GM takes $6B EV writedown. Merck eyes $32B Revolution Medicines buy. Meta expands nuclear deals for AI. Trump's tariff, drug price, mortgage policies dominate headlines.
11 min read